跳至主要内容
临床试验/NCT02205580
NCT02205580Unknown4 期

Comparison of Three Different Rates of Continuous Intravenous Sufentanil Infusion for Postoperative Pain Management Following Coblation Tonsillectomy or Adeno-tonsillectomy in Children

Jin Ni1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2014年9月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
发起方
入组人数
60
试验地点
1
主要终点
objective pain score

研究概览

简要总结

Postoperative pain following tonsillectomy or adeno-tonsillectomy in children is severe and sometimes last for days. Sufentanil is used by epidural route for postoperative analgesia in children. There are few reports about its use for postoperative analgesia by continuous intravenous infusion. Its complications include , hypoxia, sedation, pruritus ,nausea and/or vomiting.

The investigators design this protocol to test efficacy of analgesia of three different rates of continuous intravenous sufentanil infusion for postoperative pain management following coblation tonsillectomy or adeno-tonsillectomy in children. The investigators also compare incidence rate of complications for three groups.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
5 Years 至 8 Years(Child)
性别
All
接受健康志愿者

入选标准

  • American Society of Anesthesiologists grade I or II children aged 5-8 years undergoing coblation tonsillectomy or adeno-tonsillectomy as in-patient

排除标准

  • Children with a history of adverse reaction to opioids, long-term use of opioid medications, and history of chronic pain.
  • Psychiatric illness, kidney failure, hypotension, atrioventricular block, myasthenia gravis etc.

研究组 & 干预措施

Sufentanil infusion rate 0.02μg•kg-1•h-1

Experimental

Sufentanil infusion rate 0.02μg•kg-1•h-1 lasted for 48 hours

干预措施: continuous intravenous sufentanil 0.02μg•kg-1•h-1 infusion (Drug)

Sufentanil infusion rate 0.03μg•kg-1•h-1

Experimental

Sufentanil infusion rate 0.03μg•kg-1•h-1 lasted for 48 hours

干预措施: continuous intravenous sufentanil 0.03μg•kg-1•h-1 infusion (Drug)

Sufentanil infusion rate 0.04μg•kg-1•h-1

Experimental

Sufentanil infusion rate 0.04μg•kg-1•h-1 lasted for 48 hours

干预措施: continuous intravenous sufentanil 0.04μg•kg-1•h-1 infusion (Drug)

结局指标

主要结局

objective pain score

时间窗: up to 48 hours after operation

次要结局

  • incidence rate of hypoxia(4h,8h,24h,48h after operation)

研究者

发起方
Jin Ni
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Jin Ni

Department of Anesthesiology

Guangzhou Women and Children's Medical Center

研究点 (1)

Loading locations...

相似试验